• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Cannabis Extract Patent Granted - What You Need to Know

August 28, 2017

(Photo Credit - Stephen Charles Thompson)

 

Based on a recent press release, United Cannabis Corp. (OTC:CNAB) was recently granted United States Patent No.: 9,730,911 (“the ‘911 Patent”) on “Cannabis Extracts and Methods of Preparing and Using Same” on August 15, 2017. This patent covers United Cannabis Corp.’s Prana Bio Nutrient Line of products.

 

Related: Cannabis I.P. in Focus - United Cannabis Corp.

 

The ‘911 Patent covers three types of liquid cannabinoid formulations: (1) a formulation where at least 95% of the total cannabinoids in the formulation is THCa; (2) a formulation where at least 95% of the total cannabinoids in the formulation are THCa and CBDa; and (3) a formulation where at least 95% of the total cannabinoids in the formulation are THC, CBD, and CBN.

 

Related: There's Over 100 Different Cannabinoids

 

To me, the ‘911 Patent offers United Cannabis Corp a broad scope of protection over liquid cannabinoid formulations that have high concentrations of THCa and CBDa. As the therapeutic effects of these compounds become better studied, the ‘911 Patent will pay continued dividends to United Cannabis Corp.

 

Related: Marijuana Stocks Paying Dividends

 

For those of you who read my last article on United Cannabis Corp’s intellectual property, this may seem familiar. For those of you who haven’t, I recommend giving it a read, but the tl;dr is that United Cannabis Corp’s is seeking international protection (via a PCT application) on various cannabinoid formulations that are rich in THCa, CBDa, CBNa, CBCa, THC, CBN, CNB, and/or CBC, among other things.

 

Related: What is CBG (Cannabigerol)? 

 

Interestingly, the ‘911 Patent is not part of United Cannabis Corp.’s PCT application discussed in my last article. However, both the ‘911 Patent and the PCT claim priority to United States Provisional Patent Applications 62/068,278 and 62/066,795, which means that they share common subject matter.

 

Related: Protecting Your cannabis Company's I.P.

 

The implication of the ‘911 Patent being related to the PCT application, is that the issuance of the ‘911 Patent will have implications on the various National Phase entries of the PCT. Many foreign patent offices look to how the United States and Europe analyze a given patent application, and give credence to the findings of those offices. In short, United Cannabis Corp. will likely receive the international protection that they are seeking. The exact scope of what is granted in each country remains to be seen, but I would say things are looking positively for United Cannabis Corp.’s IP portfolio.

 

Related: The First Marijuana Strain Patent Ever Granted

 

Be sure to subscribe to The Daily Marijuana Observer's Cannabis Legal Newsletter below so you never miss an important intellectual property update. 

 

D/M/O

 

About the Author: Matthew G. Miller, Esq. is Principal and Patent Attorney at MG Miller Intellectual Property Law LLC. Matt received formal training in chemistry at the University of Chicago, is very passionate about innovations in high technology, and is an amateur computer programmer. He uses this combination to develop creative, effective, and efficient intellectual property portfolios.

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.